Skip to main content

This website is intended exclusively for healthcare professionals residing and/or working in Bahrain.

Home | go to homepage
SCIENCE
  • SCIENCE
  • Asthma
  • Atopic Dermatitis
  • Cardiovascular
    • Cardiovascular
    • Atherothrombosis
    • Dyslipidemia
    • Thrombosis
  • Diabetes
  • Eosinophilic Esophagitis
  • Multiple Sclerosis
  • Nasal Polyps
  • Prurigo Nodularis
  • Rare Diseases
  • Vaccines
    • Vaccines
    • Influenza
    • Meningitis
    • Pertussis & Polio
    • RSV
PATIENT SUPPORT
  • PATIENT SUPPORT
  • Atopic Dermatitis
  • Diabetes
    • Diabetes
    • Tools And Resources
      • Tools And Resources
      • Toujeo Welcome Pack
      • Soliqua Welcome Pack
      • Pre-Ramadan assessment and Risk calculation for diabetic patients during Ramadan
      • Clinical and economic value of SOLIQUA - Pharmacist perspective
  • Nasal Polyps
  • Rare Diseases
PRODUCTS
  • PRODUCTS
  • Amaryl®
  • Apidra®
  • Aprovel®
  • Aubagio®
  • Cerezyme
  • Clexane®
  • Depakine®
  • Dupixent®
    • Dupixent®
    • Atopic Dermatitis
    • Asthma
    • Nasal Polyps
  • Lantus®
  • Lemtrada®
  • Plavix®
  • Praluent®
  • Soliqua®
    • Soliqua®
    • Soliqua®
    • SoliMix Study
    • For a Peaceful Ramadan
    • Soli-Simplify Study
  • Tavanic®
  • Toujeo®
    • Toujeo®
    • Toujeo®
    • For a Peaceful Ramadan
    • Time-in-Range
    • Real world Evidences
  • LOGIN
  • SIGN UP
  • SEARCH
    Home | go to homepage
  • LOGIN
  • SIGN UP
  • SEARCH
    Home | go to homepage
    SCIENCE
    • SCIENCE
    • Asthma
    • Atopic Dermatitis
    • Cardiovascular
      • Cardiovascular
      • Atherothrombosis
      • Dyslipidemia
      • Thrombosis
    • Diabetes
    • Eosinophilic Esophagitis
    • Multiple Sclerosis
    • Nasal Polyps
    • Prurigo Nodularis
    • Rare Diseases
    • Vaccines
      • Vaccines
      • Influenza
      • Meningitis
      • Pertussis & Polio
      • RSV
    PATIENT SUPPORT
    • PATIENT SUPPORT
    • Atopic Dermatitis
    • Diabetes
      • Diabetes
      • Tools And Resources
        • Tools And Resources
        • Toujeo Welcome Pack
        • Soliqua Welcome Pack
        • Pre-Ramadan assessment and Risk calculation for diabetic patients during Ramadan
        • Clinical and economic value of SOLIQUA - Pharmacist perspective
    • Nasal Polyps
    • Rare Diseases
    PRODUCTS
    • PRODUCTS
    • Amaryl®
    • Apidra®
    • Aprovel®
    • Aubagio®
    • Cerezyme
    • Clexane®
    • Depakine®
    • Dupixent®
      • Dupixent®
      • Atopic Dermatitis
      • Asthma
      • Nasal Polyps
    • Lantus®
    • Lemtrada®
    • Plavix®
    • Praluent®
    • Soliqua®
      • Soliqua®
      • Soliqua®
      • SoliMix Study
      • For a Peaceful Ramadan
      • Soli-Simplify Study
    • Tavanic®
    • Toujeo®
      • Toujeo®
      • Toujeo®
      • For a Peaceful Ramadan
      • Time-in-Range
      • Real world Evidences
  • LOGIN
  • SIGN UP
  • SEARCH
    • Home
    • Science
    • Cutting-Edge Science

    Science at Sanofi

    Discover a wide variety of articles, videos, podcasts, accredited courses, applications, conferences and scientific events in different therapeutic areas

    Filters

    Therapeutical Areas
    Cardiovascular
    Diabetes
    Asthma
    Atopic Dermatitis
    Nasal Polyps
    Rare diseases
    Vaccines
    Influenza
    Pertussis & Polio
    Type of Content
    Watch
    Listen
    Read

    Living with Pompe Disease series is live on Youtube Juan's story

    Professor Moeen Al Sayed video on ASMD

    Professor Tawfeq Ben Omran video on ASMD

    Professor Fatma Al-Jasmi video on ASMD

    Early diagnosis and management of IOPD

    Diagnostic challenges of LOPD

    New 2022 ADA/EASD Guidelines: GLPP-1 RA/Insulin combination is very high recommended

    Fabry

    Post Thrombotic Syndrome in Women

    Advancing therapy in suboptimally controlled basal insulin-treated type 2 diabetes (Solimix)

    About Type 2 Inflammation – Asthma

    Discover a solution to control mixed eosinophilic and allergic asthma

    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    Home | go to homepage

    SANOFI, Level 3, One JLT, Jumeirah Lake Towers (JLT), DMCC, PO Box 53899, Dubai, UAE |

    Tel.: +971 4 550 3600 | Fax: +971 4 5521050

    For further Medical Information:

    please contact: +971 565776791 or Email: medical-information.gulf@sanofi.com

    To report an adverse event:

    please call: +971 561747001 or Email: Gulf.pharmacovigilance@sanofi.com

    To report any product technical complaints, kindly contact: Email: quality.greatergulf@sanofi.com

     

    MAT-BH-2100734/V4/Oct 2022

    • Legal notice
    • Cookie policy
    • Privacy policy
    • Sitemap
    • Change country

    YOU WILL NOW BE LEAVING THE SITE

    By clicking on this link, you will be leaving Campus Sanofi website and going to another, entirely independent website.
    Please note: Sanofi provides these links as a service to its website visitors and users; however, Sanofi takes no responsibility for the information on any website but their own.

    Continue
    This website is intended exclusively for healthcare professionals residing and/or working in Bahrain.
     
    Please choose if you are a healthcare professional and wish to continue on this site or if you are a member of the public to be redirected to the Sanofi website.